UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 397

Sortiert nach

Yoga's Impact on Inflammation, Mood, and Fatigue in Breast Cancer Survivors: A Randomized Controlled Trial

Journal of clinical oncology, 2014-04, Vol.32 (10), p.1040-1049

2014

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer and aging: results of the U13 conference breast cancer panel

Breast cancer research and treatment, 2014-07, Vol.146 (1), p.1-6

2014

Link zum Volltext

Verfügbarkeit prüfen

Locoregional Failure Rates Are Low After Mastectomy in a Modern Cohort of Patients With T1-T2 Tumors With 1-3 Pathologically Involved Lymph Nodes

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S223-S223

2015

Link zum Volltext

Verfügbarkeit prüfen

Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells

Blood, 1996-04, Vol.87 (7), p.2632-2640

1996

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of sequentially administered low-dose mitomycin-C (MMC) and irinotecan (CPT-11) in women with metastatic breast cancer (MBC)

Annals of oncology, 2008-08, Vol.19 (8), p.1417-1422

2008

Link zum Volltext

Verfügbarkeit prüfen

Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy

The Journal of clinical investigation, 2000-07, Vol.106 (1), p.117-124

2000

Link zum Volltext

Verfügbarkeit prüfen

Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review

Supportive care in cancer, 2013-10, Vol.21 (10), p.2679-2686

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract P3-12-01: Locoregional failure rates do not vary by breast cancer subtype after mastectomy in a modern cohort of patients with T1-2 tumors with 1-3 pathologically involved lymph nodes

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P3-P3-12-01

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-09-18: Characterization of circulating myeloid derived suppressor cells and cytokines in patients undergoing neo-adjuvant chemotherapy for breast cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P4-P4-09-18

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase I trial of liposomal encapsulated doxorubicin (Myocet™; D-99) and weekly docetaxel in advanced breast cancer patients

Annals of oncology, 2005-07, Vol.16 (7), p.1087-1093

2005

Link zum Volltext

Verfügbarkeit prüfen

Determination of refractive index profiles of Ag+ -Na+ ion-exchange multimode strip waveguides by variable wavefront shear double-refracting interferometry microinterferometry

Applied Optics, 2006-02, Vol.45 (4), p.756-763

2006

Link zum Volltext

Verfügbarkeit prüfen

Side diffusion modeling by the explicit consideration of a space-charge buildup under the mask during strip waveguide formation in the Ag+ -Na+ field-assisted ion-exchange process

Applied Optics, 2006-02, Vol.45 (4), p.619-625

2006

Link zum Volltext

Verfügbarkeit prüfen

Stem Cell Factor Enhances Interleukin-2–Mediated Expansion of Murine Natural Killer Cells In Vivo

Blood, 1997-11, Vol.90 (9), p.3647-3653

1997

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-11-07: Endothelial progenitor cells as novel markers of anthracycline induced cardiac injury

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P2-P2-11-07

2012

Link zum Volltext

Verfügbarkeit prüfen

PD10-01: Prevalence of Dysfunctional Fanconi Anemia (FA) DNA Repair Pathway in Breast Cancer

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.PD10-01-PD10-01

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of exemestane in combination with fulvestrant in postmenopausal women with hormone responsive advanced breast cancer: no evidence of a pharmacokinetic interaction between exemestane and fulvestrant

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.6131

2009

Link zum Volltext

Verfügbarkeit prüfen

EpCAM-negative cancer–associated circulating cells (CACS) in blood samples of women with triple-negative breast cancer (TNBC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e11559-e11559

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of neoadjuvant chemotherapy (NCT) with weekly nanoparticle albumin-bound paclitaxel (Nab-P), carboplatin (CBP), and bevacizumab (BEV) in women with clinical stages II-III breast cancer (BC): Pathologic response prediction by changes in angiogenic volume (AV) by dynamic contrast magnetic resonance imaging (DCE-MRI)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.604-604

2010

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of bendamustine and fractionated stereotactic radiotherapy (FSRT) in patients with one to three brain metastases from solid malignancies

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.TPS146-TPS146

2010

Link zum Volltext

Verfügbarkeit prüfen

Nurses' attitudes toward pain, pain assessment, and pain management practices in long-term care facilities

Pain management nursing, 2001-12, Vol.2 (4), p.154-162

2001

Link zum Volltext

Verfügbarkeit prüfen

Antiidiotype (Ab2) Vaccine Therapy for Cutaneous T-Cell Lymphoma

Annals of the New York Academy of Sciences, 1993-08, Vol.690 (1), p.376-377

1993

Link zum Volltext

Verfügbarkeit prüfen

Phase I trial of liposomal encapsulated doxorubicin (Myocet super(TM); D-99) and weekly docetaxel in advanced breast cancer patients

Annals of oncology, 2005-07, Vol.16 (7), p.1087-1093

2005

Link zum Volltext

Verfügbarkeit prüfen

Anti-idiotype antibodies as potential therapeutic agents for human breast cancer

Advances in experimental medicine and biology, 1994, Vol.353, p.139

1994

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of sequentially administered mitomycin (MMC) and irinotecan (CPT-11) in patients (pts) with metastatic breast cancer (MBC)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.10542-10542

2006

Link zum Volltext

Verfügbarkeit prüfen

Capecitabine: nursing implications of a new oral chemotherapeutic agent

Oncology nursing forum, 1999-05, Vol.26 (4), p.753

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 397

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(358)
Mit Volltextzugriff
(366)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(206)
Humans
(164)
Life Sciences & Biomedicine
(163)
Female
(122)
Middle Aged
(106)
Male
(105)
Adult
(100)
Aged
(71)
Oncology
(68)
Biological And Medical Sciences
(66)
Medical Sciences
(61)
Hematology
(59)
Leukemia, Myeloid, Acute - Genetics
(56)
Prognosis
(51)
Adolescent
(44)
Hematologic And Hematopoietic Diseases
(42)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(42)
Mutation
(39)
Treatment Outcome
(39)
Aged, 80 And Over
(38)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(80)
Journal Of Clinical Oncology
(39)
Leukemia
(22)
Blood Advances
(10)
Cancer Research
(10)
Pediatric Research
(8)
Journal Of Antimicrobial Chemotherapy
(7)
Haematologica
(5)
Proceedings Of The National Academy Of Sciences - Pnas
(5)
Surface Science
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Yoga's Impact on Inflammation, Mood, and Fatigue in Breast Cancer Survivors: A Randomized Controlled Trial

Breast cancer and aging: results of the U13 conference breast cancer panel

Locoregional Failure Rates Are Low After Mastectomy in a Modern Cohort of Patients With T1-T2 Tumors With 1-3 Pathologically Involved Lymph Nodes

Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells

Phase II study of sequentially administered low-dose mitomycin-C (MMC) and irinotecan (CPT-11) in women with metastatic breast cancer (MBC)

Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy

Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review

Abstract P3-12-01: Locoregional failure rates do not vary by breast cancer subtype after mastectomy in a modern cohort of patients with T1-2 tumors with 1-3 pathologically involved lymph nodes

Abstract P4-09-18: Characterization of circulating myeloid derived suppressor cells and cytokines in patients undergoing neo-adjuvant chemotherapy for breast cancer

Phase I trial of liposomal encapsulated doxorubicin (Myocet™; D-99) and weekly docetaxel in advanced breast cancer patients

Determination of refractive index profiles of Ag+ -Na+ ion-exchange multimode strip waveguides by variable wavefront shear double-refracting interferometry microinterferometry

Side diffusion modeling by the explicit consideration of a space-charge buildup under the mask during strip waveguide formation in the Ag+ -Na+ field-assisted ion-exchange process

Stem Cell Factor Enhances Interleukin-2–Mediated Expansion of Murine Natural Killer Cells In Vivo

Abstract P2-11-07: Endothelial progenitor cells as novel markers of anthracycline induced cardiac injury

PD10-01: Prevalence of Dysfunctional Fanconi Anemia (FA) DNA Repair Pathway in Breast Cancer

Phase II trial of exemestane in combination with fulvestrant in postmenopausal women with hormone responsive advanced breast cancer: no evidence of a pharmacokinetic interaction between exemestane and fulvestrant

EpCAM-negative cancer–associated circulating cells (CACS) in blood samples of women with triple-negative breast cancer (TNBC)

Phase I study of bendamustine and fractionated stereotactic radiotherapy (FSRT) in patients with one to three brain metastases from solid malignancies

Nurses' attitudes toward pain, pain assessment, and pain management practices in long-term care facilities

Antiidiotype (Ab2) Vaccine Therapy for Cutaneous T-Cell Lymphoma

Phase I trial of liposomal encapsulated doxorubicin (Myocet super(TM); D-99) and weekly docetaxel in advanced breast cancer patients

Anti-idiotype antibodies as potential therapeutic agents for human breast cancer

Phase II study of sequentially administered mitomycin (MMC) and irinotecan (CPT-11) in patients (pts) with metastatic breast cancer (MBC)

Capecitabine: nursing implications of a new oral chemotherapeutic agent

Suchergebnisse filtern